Lyell Immunopharma Inc. Common Stock (LYEL)

Stock · NASDAQ · Health Care

$14.53as of 8/28/2026

Price chart

Insider transactionsShow all transaction typesRevenue Growth

No technical signal is currently active for this symbol.

Support level

$12.7

Industry

Biotechnology: Pharmaceutical Preparations

Chosen by industry and closest market cap.

LYEL
Lyell Immunopharma Inc. Common Stock
$14.53
▼ 0.55%
Market cap $315.37MP/E —
VNDA
Vanda Pharmaceuticals Inc. Common Stock
$5.29
▼ 2.76%
Market cap $314.51MP/E —
$4.27$9.94
ORGO
Organogenesis Holdings Inc. Class A Common Stock
$1.74
▼ 0.00%
Market cap $301.10MP/E 84.95
$1.54$7.08
IRD
Opus Genetics Inc. Common Stock
$3.7
▼ 3.90%
Market cap $300.54MP/E —
$1.17$5.81
ZNTL
Zentalis Pharmaceuticals Inc. Common Stock
$3.8
▼ 2.06%
Market cap $331.02MP/E —
$1.21$6.95
FULC
Fulcrum Therapeutics Inc. Common Stock
$3.85
▲ 0.00%
Market cap $283.06MP/E —
$2.83$15.74
UPB
Upstream Bio Inc. Common Stock
$6.68
▼ 1.62%
Market cap $349.38MP/E —
$5.85$33.68

Symbol	Market cap	P/E ratio	Price	1D	52-week range
LYEL Lyell Immunopharma Inc. Common Stock	$315.37M	—	$14.53	▼ 0.55%
VNDA Vanda Pharmaceuticals Inc. Common Stock	$314.51M	—	$5.29	▼ 2.76%	$4.27$9.94
ORGO Organogenesis Holdings Inc. Class A Common Stock	$301.10M	84.95	$1.74	▼ 0.00%	$1.54$7.08
IRD Opus Genetics Inc. Common Stock	$300.54M	—	$3.7	▼ 3.90%	$1.17$5.81
ZNTL Zentalis Pharmaceuticals Inc. Common Stock	$331.02M	—	$3.8	▼ 2.06%	$1.21$6.95
FULC Fulcrum Therapeutics Inc. Common Stock	$283.06M	—	$3.85	▲ 0.00%	$2.83$15.74
UPB Upstream Bio Inc. Common Stock	$349.38M	—	$6.68	▼ 1.62%	$5.85$33.68

P/E shows — for peers not currently carrying a live signal of their own.

March 31, 2026

Top holders this quarter

See the full, filterable feed with live charts on the MarketWall dashboard.